Murugappan Sathappa
  • Industry Scientist, Kymera Therapeutics
Research fields
  • Biochemistry, Biophysics
Personal information


PhD, University of Connecticut, 2017

Research focus

Targeted Protein Degradation, Induced Proximity, Biochemistry, Biophysics, protein-small molecule interactions, drug discovery


1) Malhotra K, Sathappa M, Landin JS, Johnson AE, Alder NN. Nat. Struct. Mol. Biol. 20: 965-72. (2013)
2) Baile MG, Sathappa M, Lu YW, Pryce E, Whited K, McCaffery JM, Han X, Alder NN, Claypool SM. J. Biol. Chem. 289: 1768-78. (2014)
3) Sathappa M, Alder NN. Biochimica Et Biophysica Acta (BBA)-Biomembranes. 1858(6), 1362-1372 (2016)
4) Sathappa M, Alder NN. Bioprotocols Bio-protocol 6(22): e2030 (2016)
5) Mitchell W, Emily A, Tamucci JD, Boyd K, Sathappa M, et al. J.Biol.Chem. 295(21):7452-7469 (2020)
6) Persky NS, Hernandez D, Do Carmo M, Brenan L, Cohen O, Kitajima S, Nayar U, Walker A, Pantel S, Lee Y, Cordova J, Sathappa M et al. Nat. Struct. Mol. Biol. 27, 92-104 (2020)
7)Reidenbach, A. G., Mesleh, M. F., Casalena, D., Vallabh, S. M., Dahlin, J. L., Leed, A. J., Minikel. et.al J.Biol.Chem. 295(39):13516-13531 (2020)
8)Miller PG*, Sathappa M*, Moroco JA*, Jiang W, Yue Q et.al Nat Commun 13, 3778 (2022)
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.